RGEN Valuation

Repligen Corp

Add to Watchlist

Advanced Chart

121.735

-0.135(-0.111%)1D

Overview
Forecast
Valuation
Earnings

RGEN Relative Valuation

RGEN's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, RGEN is overvalued; if below, it's undervalued.

Historical Valuation

Repligen Corp (RGEN) is now in the Fair zone, suggesting that its current forward PE ratio of 68.94 is considered Fairly compared with the five-year average of 87.85. The fair price of Repligen Corp (RGEN) is between 105.49 to 166.41 according to relative valuation methord.

Relative Value

Fair Zone

105.49-166.41

Current Price：121.73

Fair

Trailing

Forward

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

3.44

P/B

Median3y

4.66

Median5y

5.70

1.82

FCF Yield

Median3y

1.13

Median5y

0.84

Competitors Valuation Multiple

The average P/S ratio for RGEN's competitors is 4.62, providing a benchmark for relative valuation. Repligen Corp Corp (RGEN) exhibits a P/S ratio of 9.32, which is 101.79% above the industry average. Given its robust revenue growth of 10.44%, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap